Bayer Suspends Sale of Baycol, Cholesterol Lowering Drug

Published: 2001-08-14 06:59:00

Updated: 2001-08-14 06:59:00

Bayer Korea announced on August 9 that the sale of its cholesterol lowering drug Baycol, which was placed on sale back in November 1999, was suspended in Korea.

The decision to halt the sale of Baycol, issued from the headquarters of Bayer, was announced throughout the world in response to cas...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK